The Activity of Valproic Acid in the Treatment of Refractory Hyperleukocytosis in a Child with Acute Lymphoblastic Leukemia

Basit Öğe Kaydı
dc.contributor.authorKose, Dogan
dc.contributor.authorKoksal, Yavuz
dc.date.accessioned2020-03-26T18:43:47Z
dc.date.available2020-03-26T18:43:47Z
dc.date.issued2013
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractHyperleukocytosis may be associated with an early morbidity and mortality due to leukostasis. Cytoreductive therapies-such as steroids, hydroxiurea, exchange transfusion, and leukapheresis-have been used for the prevention of leukostasis. Herein, the valproic acid used for the treatment of the hyperleukocytosis did not respond to known therapies in a child; lymphoblastic lymphoma developed bone marrow relapse under the treatment is discussed.en_US
dc.identifier.doi10.3109/08880018.2013.797063en_US
dc.identifier.endpage585en_US
dc.identifier.issn0888-0018en_US
dc.identifier.issn1521-0669en_US
dc.identifier.issue6en_US
dc.identifier.pmid23659619en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage583en_US
dc.identifier.urihttps://dx.doi.org/10.3109/08880018.2013.797063
dc.identifier.urihttps://hdl.handle.net/20.500.12395/29888
dc.identifier.volume30en_US
dc.identifier.wosWOS:000323110300012en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTAYLOR & FRANCIS INCen_US
dc.relation.ispartofPEDIATRIC HEMATOLOGY AND ONCOLOGYen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectchildrenen_US
dc.subjecthyperleukocytosisen_US
dc.subjectvalproic aciden_US
dc.titleThe Activity of Valproic Acid in the Treatment of Refractory Hyperleukocytosis in a Child with Acute Lymphoblastic Leukemiaen_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu